Hong Kong Pharmaceuticals & Biotech Stocks

  • 7D-0.6%
  • 1Y46.0%
  • Avg. PE14.4x
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
8329Shenzhen Neptunus Interlong Bio-techniqueHK$0.243.9%5.3%HK$402.7mn/aP/E9.2xn/an/a
2142HBM HoldingsHK$9.080.1%n/aHK$1.6bHK$16.17P/S14.6xE79.2%n/a
1011China NT Pharma GroupHK$0.130.8%-24.9%HK$464.3mn/aP/B12.5xn/a0%
455Tianda PharmaceuticalsHK$0.190%28.7%HK$415.0mn/aP/E-27.6xn/a0.7%
239Pak Fah Yeow InternationalHK$1.800%-26.2%HK$561.0mn/aP/S5.1xn/a4.2%
1889Sanai Health Industry GroupHK$0.090%n/aHK$0n/an/an/a0%
1498PuraPharmHK$0.700%-5.4%HK$259.6mn/aP/E8.2xn/a0%
575Regent Pacific GroupHK$0.20-1.0%145.0%HK$364.5mn/aP/S38.7xn/an/a
690Uni-Bio Science GroupHK$0.097-1.0%-38.2%HK$621.6mn/aP/S3xn/an/a
897Wai Yuen Tong Medicine HoldingsHK$0.33-1.5%16.1%HK$400.3mn/aP/E-2.4xn/a0%
2552Hua Medicine (Shanghai)HK$4.17-0.2%39.5%HK$4.0bHK$11.40P/S383.9xE-1.6%n/a
8049Jilin Province Huinan Changlong Bio-pharmacyHK$1.25-1.6%-3.1%HK$700.3mn/aP/E4.6xn/a3.3%
1652Fusen PharmaceuticalHK$5.20-0.4%50.7%HK$4.1bn/aP/E48.9xn/a0.2%
858Extrawell Pharmaceutical HoldingsHK$0.15-5.1%64.4%HK$353.7mn/aP/E2.7xn/an/a
1672Ascletis PharmaHK$2.84-0.7%-1.7%HK$3.0bHK$3.69P/S70.8xE74.2%n/a
8225China Health GroupHK$0.45-5.3%-50.0%HK$442.4mn/aP/E6.1xn/an/a
6978Immunotech BiopharmHK$16.82-0.4%n/aHK$7.5bHK$14.76P/B6.4xE67.7%n/a
2161JBM (Healthcare)HK$1.24-3.1%n/aHK$895.3mn/aP/E21.8xn/an/a
2633Jacobson PharmaHK$0.96-2.0%-33.8%HK$1.9bn/aP/E9.7xn/a4.7%
2181MabpharmHK$1.20-0.8%17.6%HK$4.9bn/aP/S182.3xn/an/a
1558YiChang HEC ChangJiang PharmaceuticalHK$8.25-0.6%-52.5%HK$7.3bHK$11.71P/E7.3xE-18.9%0%
2348Dawnrays Pharmaceutical (Holdings)HK$1.47-2.0%22.5%HK$2.3bn/aP/E7.1xn/a4.4%
1875TOT BIOPHARM InternationalHK$3.96-2.2%7.0%HK$2.3bHK$7.45P/S84.3xS35.5%n/a
719Shandong Xinhua PharmaceuticalHK$4.77-2.9%13.8%HK$3.0bn/aP/E7.4xn/a3.7%
Page 2 of 4